05-19339. Memorandum of Understanding between the Food and Drug Administration, Forensic Chemistry Center and the Federal Bureau of Investigation  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and the Federal Bureau of Investigation (FBI). The purpose of this MOU is to establish the general policies and procedures that will govern administrative, logistical, and operational support to FBI missions including cost reimbursable activities.

    DATES:

    The agreement became effective December 22, 2004.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    For the FDA: Fred Fricke, Food and Drug Administration, Forensic Chemistry Center, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700.

    For the FBI: David L. Wilson, Federal Bureau of Investigation Laboratory, Chemical Biological Sciences Unit, Quantico, VA 22135, 703-632-7766.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

    Start Signature

    Dated: September 20, 2005.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature Start Printed Page 56713

    Start Printed Page 56714

    Start Printed Page 56715

    Start Printed Page 56716

    Start Printed Page 56717

    Start Printed Page 56718

    Start Printed Page 56719

    Start Printed Page 56720

    End Supplemental Information

    BILLING CODE 4160-01-S

    [FR Doc. 05-19339 Filed 9-27-05; 8:45 am]

    BILLING CODE 4160-01-C

Document Information

Effective Date:
12/22/2004
Published:
09/28/2005
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
05-19339
Dates:
The agreement became effective December 22, 2004.
Pages:
56712-56720 (9 pages)
Docket Numbers:
FDA 225-04-4007
PDF File:
05-19339.pdf